The development of vaccine is a complex process. CD BioGlyco has developed a glyco-based vaccine development platform to provide customers with better solutions for vaccine design, production, and optimization. We provide glycoprotein-based vaccine development, glycopeptide-based cancer vaccine development, carbohydrate-based vaccine development, and carbohydrate-based vaccine adjuvant development services to help customers accelerate their vaccine development and preclinical research to combat new infections and meet medical needs.